Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Irisin Level & FDNC5 Genetic Polymorphism Can Predict the Presence &Severity of Coronary Artery Disease in Patients With Type II DM?

NCT04957823 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT04957823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04957823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Irisin Level & FDNC5 Genetic Polymorphism Can Predict the Presence &Severity of Coronary Artery Disease in Patients With Type II DM?
Lead sponsor
Sohag University
Phase
Observational
Overall status
Completed
Start date
April 20, 2021
Completion date
October 30, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irisin gene polymorphism in type ii diabetic patients